IGS Cancer Research Spans from Molecules to Modeling
IGS researchers work to unravel the causes of cancer growth and explore the possibility of precision treatment based on an individual's genetic makeup.
Our researchers study head and neck cancer, scientifically known as head and neck squamous cell carcinoma (HNSCC), human genome variation and its impact on cancer, as well as building models of cancer with a focus on solid malignancies, the immune system, and therapeutic interventions. In addition, they use agent-based modeling in an effort to develop "digital twins" that can simulate how an individual's cancer might progress or how they would respond to specific drugs.
IGS faculty works closely with the scientists and clinicians at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). IGS Director Elana J. Fertig, PhD, FAIMB, also serves as the Associate Director for Quantitative Science at UMGCCC.